Intracranial Hemorrhages Clinical Trial
Official title:
Safety and Efficacy of Remote Ischemic Conditioning for Spontaneous Intracerebral Hemorrhage
The purpose of this study is to determine the efficacy and safety of remote ischemic conditioning in treating acute intracerebral hemorrhage.
Spontaneous intracerebral hemorrhage is a major cause of disability and mortality among different types of stroke, and few effective treatment options are available. Therefore, it is essential to develop new approaches to improve the prognosis of these patients. Recently, remote ischemic conditioning (RIC), a method that involves inducing multiple brief episodes of ischemia and reperfusion in the limbs, has been indicated to exert neuroprotective effects in experimental stroke. The underlying neuroprotective mechanism triggered by RIC induces gene expression, alters pathways, promotes neurogenesis and blood vessel development, reduces oxidative stress and neuronal apoptosis, and inhibits proinflammatory signals. Previously, several clinical trials have shown that single or repeated RIC treatments for cerebrovascular diseases are feasible and safe. Therefore, we hypothesize that RIC could improve functional outcome in patients with intracerebral hemorrhage. We design this prospective, multicenter, randomized controlled trial to evaluate the efficacy and safety of RIC in treating intracerebral hemorrhage. ;
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT03969732 -
Multimodal Biomarkers for Diagnosis and Prognosis in CAA
|
Phase 3 | |
Recruiting |
NCT05968053 -
Detection of Microplastics and Nanoplastics in Neurosurgery Patients (DT-MiNi)
|
||
Recruiting |
NCT02962349 -
TRansfusion Strategies in Acute Brain INjured Patients
|
N/A | |
Recruiting |
NCT03950076 -
EdoxabaN foR IntraCranial Hemorrhage Survivors With Atrial Fibrillation (ENRICH-AF)
|
Phase 4 | |
Completed |
NCT03542656 -
Application of Amyloid PET in Cerebral Amyloid Angiopathy
|
Phase 3 | |
Active, not recruiting |
NCT05626504 -
Outcome Study of the Pipeline Embolization Device With Vantage Technology in Unruptured Aneurysms
|
||
Recruiting |
NCT03495206 -
Safety, Tolerability and Pharmacokinetics of Y-2(Edaravone And Borneol) Sublingual Tablet
|
Phase 1 | |
Not yet recruiting |
NCT04229758 -
Restarting Anticoagulation After Traumatic Intracranial Hemorrhage
|
Phase 3 | |
Recruiting |
NCT02135783 -
Decompressive Craniectomy Combined With Hematoma Removal to Treat ICH
|
N/A | |
Enrolling by invitation |
NCT02050971 -
Autologous Cord Blood Infusion for the Prevention and Treatment of Prematurity Complications In Preterm Neonates
|
Phase 1 | |
Completed |
NCT01193270 -
Vitamin E for Extremely Preterm Infants
|
Phase 1 | |
Completed |
NCT02881957 -
Hypovitaminosis D in Neurocritical Patients
|
Phase 2/Phase 3 | |
Completed |
NCT03364634 -
Intracranial Pressure After Decompressive Craniectomy
|
N/A | |
Completed |
NCT00226096 -
Intensive Blood Pressure Reduction in Acute Cerebral Haemorrhage
|
N/A | |
Recruiting |
NCT06081283 -
Antiseizure Medication in Seizure Networks at Early Acute Brain Injury
|
Phase 4 | |
Recruiting |
NCT04459806 -
Intracranial PrEssure Time dOse (ImPETO)
|
||
Recruiting |
NCT05874050 -
Arterial Pressure and Surgical Hemostasis in Elective Neurosurgery.
|
||
Not yet recruiting |
NCT05138341 -
Minimal Invasive Surgical Intracerebral Hemorrhage Removal
|
N/A | |
Terminated |
NCT03660618 -
LSFG-SKIN, Laser Speckle Flowgraphy
|
N/A | |
Recruiting |
NCT06370520 -
Screening Emotions in Adolescents at the Hospital for mTBI
|